Abstract
COMMITTEE MEMBERS
JORGE GUTIERREZ-ACEVES, MD
President
GLENN PREMINGER, MD
Past President
ADRIAN JOYCE, MD
President‐Elect
MARGARET S. PEARLE, MD, PhD
Secretary General
LI-MING SU, MD
Secretary General‐Elect
CHANDRU SUNDARAM, MD
Treasurer
BRIAN MATLAGA, MD
Director of Education
BRADLEY SCHWARTZ, MD
Associate Director of Education
BEN H. CHEW, MD, MSc, FRCSC
Research Chair
MICHELE PAOLI
Executive Director
BOARD OF DIRECTORS
JEFFREY CADEDDU, MD, USA
Director
NORBERTO O. BERNARDO, MD, Argentina
Director
EDUARDO MAZZUCCHI, MD, BRAZIL
Member-at-Large
JEAN JOSEPH, MD, MBA, FACS, USA
Director
SEUNG HYUN JEON, MD, Korea
Director
JIHAD KAOUK, MD, USA
Member-at-Large
OLIVIER TRAXER, MD, France
Director
HASSAN RAZVI, MD, Canada
Director
ABHAY RANE, MD, United Kingdom
Director
ANTHONY C.F. NG, MD, Hong Kong
Director
TOMONORI HABUCHI, MD, Japan
Director
GUIDO GIUSTI, MD, Italy
Director
THOMAS KNOLL, MD, Germany
Member-at-Large
ARTHUR D. SMITH, MD
STEPHEN Y. NAKADA, MD, FACS
JAIME LANDMAN, MD
MANTU GUPTA, MD
BEN H. CHEW, MD, MSc, FRCSC
Chair, CROES (Clinical Research Office of the Endourology Society)
ASHUTOSH TEWARI, MD
President, SURS (Society of Urological Robotic Surgery)
LEE RICHSTONE, MD
President, Engineering & Urology Society
DIRK LANGE, MD
International Society for Urological Stents
CLINT BAHLER, MD
Young Endourologists
ESTEBAN EMILIANI, MD
Young Endourologists
TOM POLASCIK, MD
Chair, Focal Therapy Society
Brian D. Duty, MD, Chairman
Khurshid R. Ghani, MD, MS
Athanasios Papatsoris, MD
Michael S. Borofsky, MD
Zhamshid Okhunov, MD
Chandru P. Sundaram, MD, Treasurer
Brian Matlaga, MD, Associate Director of Education
Nicole Miller, MD, Chairman
Olivier Traxer, MD
Ravindra Sabnis, MD
Ken Pace, MD
Benjamin Lee, MD
Jens Rassweiler, MD
Glenn Preminger, MD
Mantu Gupta, (Video)
Margaret S. Pearle (ex-offico), MD, PhD, Secretary General
Li-Ming Su, MD, Chairman
Lorenzo Defidio, MD
Robert Figenshau, MD
Tom Chi, MD
Guohua Zeng, MD
Oscar Fugita, MD
Mohamad Allaf, MD
Chandru P. Sundaram, MD, Chair
Li-Ming Su, MD
Hassan Razvi, MD
Bodo E. Knudsen, MD, FRCSC
Margaret S. Pearle, MD, PhD, Secretary General
Brian Matlaga, MD, Director of Education
Ashutosh Tewari, MD, SURS Chair
Bradley Schwartz, MD, Associate Director of Education
Ben H. Chew, MD, MSc, FRCSC, Reseach Chair
Chandru Sundaram, MD, Treasurer
Brian Matlaga, MD, Director of Education
Bradley Schwartz, MD, Associate Director of Education
Jihad Kaouk, MD
Evangelos Liatsikos, MD
Roger Sur, MD
Bodo E. Knudsen, MD, FRCSC
Andreas Gross, MD
Zhamid Okhunov, MD
Margaret S. Pearle, MD, PhD, Secretary General
Chandru P. Sundaram, MD, Treasurer
Gopal Badlani, MD, Chairman
Raju Thomas, MD, FACS, MHA, MD
Ali R. Kural, MD
Ralph V. Clayman, MD
Marius Conradie, MD
Graham Watson, MD
Brian Eisner, MD, Chair
Fabio Vicentini, MD (Lap/Stones)
Kevin Koo, MD (Stones)
Riccardo Autorino, MD (Robotics)
John Davis, MD (Robotics)
Igor Sorokin, MD (Stones/Robotics)
Thomas Herrmann, MD
Eduardo Mazzucchi, MD, Chair
Altug Tuncel, MD
Joseph Wong, MD
Abbas Basiri, MD
Samuel Vincent Yrastorza, MD
Wilson Molina, MD
Jodi Antonelli, MD
Yasser Farahat, MD
Timothy Averch, MD, Chair
Bernardo Rocco, MD, Vice Chair
Justin Ziemba, MD
Amy Krambeck, MD
Matthew Bultitude, MD
Ahmed Ghazi, MD
Ben H. Chew, MD, MSc, FRCSC, Research Chair
Thomas Tailly, MD
Benjamin Canales, MD
Kristina Penniston, PhD, RDN
Chuck Scales, MD
Craig Rogers, MD
Jihad Kaouk, MD
Tom Polascik, MD
Bhaskar Somani, MD
Brian Matlaga, MD, Chair
Michelle Jo Semins, MD, Co-Chair
Jean Joseph, MD
Zeph Okeke, MD
Marianne Brehmer, MD
Kymora Scotland, MD
Sara Best, MD
Damien Bolton, MD
Australia
Alex Meller, MD
Brazil
Jason Lee, MD
Canada
Jian Xing Li, MD
China
Xio Feng Gao, MD
China
Ali Goezen, MD
Germany
Athanasios Papatsoris, MD
Greece
Joseph Wong, MD
Hong Kong
Madhu Agrawal, MD
India
Ali Tabibi, MD
Iran
David Lifshitz, MD
Israel
Silvia Proietti, MD
Italy
Ryoichi Shiroki, MD
Japan
Atsushi Takenaka, MD
Japan
Ill Young Seo, MD
Korea
Daniel Olvera-Posada, MD
Mexico
Samuel Vincent Yrastorza, MD
Philippines
Mohammed Alomar, MD
Saudi Arabia
Ömer Tuncay, MD
Turkey
Yasser Farahat, MD
UAE
Bhaskar Somani, MD
United Kingdom
Roger Sur, MD
United States
Necole Streeper, MD
United States
Benjamin Lee, MD
United States
2020 RECIPIENT OF THE ‘‘ARTHUR’’ AWARD
Prof. Bhaskar K. Somani graduated from Manipal Academy of Higher Education (MAHE), KMC Mangalore, India. He came to UK in 2000 and did his basic surgical training in Wales and Birmingham before moving to Scotland for his urology training. He became a Consultant Urological Surgeon and Endourology lead in University Hospital Southampton in 2012. During training he did short fellowships in France and India.
Prof. Somani has served in various positions across different organizations. He is in the EAU urolithiasis guidelines panel, ESUT endourology committee, EAU live surgery committee, EAU Standardisation in Surgical Education (SISE) committee and EAU medical undergraduate training programme committee. He is also a member of the European School of Urology (ESU) training and research group. He is the Endourological society UK representative and is in the society's research group. Prof. Somani became an elected member of BAUS executive academic committee (2016–2018), endourology committee (2019–2021), FRCS MCQ panel (2015–2018) and endourology lead for UK boot camp (2015–2018). He is also served as NICE specialist advisor for interventional procedures and invited expert for NICE urological infections guidelines. From 2013–2018 Prof. Somani served as the EAU residents education programme (EUREP) hands-on-training (HOT) tutor for ureteroscopy and was appointed as the coordinator of EUREP HOT in 2019.
Amongst other prizes Prof. Somani was the winner of NHS Emerging Leader (Thames Valley and Wessex region) in 2015. He was awarded Honorary Fellowship (FRCS) by Royal College of Physicians and Surgeons of Glasgow in 2020, and Fellow of Faculty of Surgical Trainers by Royal College of Surgeons Edinburgh in 2017. His papers have won the EULIS Clinical Research Award (2019) and Best Paper in the Literature Award (2017). He also won the Unity 101 Annual Community Award in Southampton for 2020. Prof. Somani is the current president of PETRA (Progress in Endourology, Technology and Research Association) and I-TRUE (International Training and Research in Uro-Oncology and Endourology) groups. He became the founder and course director of Urology Global Residents I-TRUE Postgraduate Programme (UROGRIPP).
Prof. Somani has a H-index of 42 and has more than 330 published papers in PubMed indexed journals with over 5500 citations. He has amassed a grant income of over $2 million and is a Chief or Principal investigator of 9 trials. He is the senior author of the EAU standardized Endoscopic stone treatment (EST) curriculum which is now adopted in over 20 countries. He is on the editorial board of 4 journals and is a reviewer for 12 journals.
Prof. Somani has been invited as a speaker to perform live surgery or for moderations in more than 25 countries worldwide. Apart from Endourology and related work, his current research interests include diagnosis and management of urinary tract infections, stent and catheter related infections, quality of life, use of artificial intelligence, surgical education and simulation. His clinical and research work has been covered by BBC, ITV, Daily Mail, The Telegraph and other newspapers and media articles on a number of occasions. With dedication, commitment and passion for research and teaching, Prof. Somani collaborates nationally and internationally sharing his research and teaching successfully across the world. He has published excellent clinical outcomes and his outcome and research translate into patient benefit.
2020 RECIPIENT OF THE RALPH CLAYMAN ‘‘MENTOR’’ AWARD
As an endourologist, Dr. Traxer's main goal is to improve the knowledge of urinary stone disease and endourology. He particularly focuses on laser technology and RIRS. Dr. Traxer is responsible for the minimally invasive surgery section at Tenon Hospital, University Pierre et Marie Curie, Paris, and has published more than 360 peer- reviewed papers.
Dr. Traxer is a board member of the Endourological Society, the French Association of Urology (AFU) and EAU board member of the EULIS, ESUT. He was also the treasurer of SIU. In 2010 at the Chicago, IL, WCE, he received the Arthur Smith Award and was Chair at the World Congress of Endourology WCE 2018 in Paris.
2020 RECIPIENT OF THE KARL STORZ ‘‘LIFETIME ACHIEVEMENT’’ AWARD
Professor, Department of Urology, University of California San Francisco
Dr. Marshall Stoller has dedicated his more than 35-year academic career at the University of California, San Francisco to pursue minimally invasive treatment and better understanding of nephrolithiasis. He has trained close to 35 fellows and over 100 residents in the utilization and techniques of endourology. He has wide research interests. Dr. Stoller helped bring laparoscopic approaches to urologic surgery and was involved in the early development of robotic applications in this arena. He was among the first to appreciate that urinary stone disease is associated with cardiovascular health and postulated that stone disease may represent a vascular, rather than a urinary, abnormality in the kidney.
Dr. Stoller has received numerous NIH grants to study stone disease, including a grant in which he developed the fruit fly as a unique invertebrate model to study stone pathogenesis, utilizing ICP-OES to assess the role of heavy metals in stone nidi. He also popularized the re-examination of Randall plaques to better understand the beginnings of stone formation within the renal papilla. He illustrated that early stone elements start in the proximal periphery of the renal papilla and, with time, they develop within the distal tip of the papilla that can be appreciated via endoscopic view. In addition, Dr. Stoller has developed new approaches to many other disease processes, including the use of posterior tibial nerve stimulation (PTNS) for pelvic floor dysfunction, the realization of the utility of lemon juice products to increase urinary citrate, the formulation of Moonstone® as a non-prescription option to increase urinary citrate, the use of tagged microbubbles to facilitate a new minimally invasive technique to break up stones (developed in collaboration with Stanford Engineering and with Nobel Laureate Bob Grubbs at Caltech). He also spearheaded the randomized controlled trial utilizing alpha lipoic acid as a potential new novel treatment of cystine nephrolithiasis.
Equally important to Dr. Stoller has been his dedication to teaching and mentorship. He enjoys teaching medical students (teaching awards at UCSF), teaching and mentoring urologic residents (teaching awards) and endourology fellows (Urology Care Foundation Mentor of the Year award). He has also reached out to those working in many other disciplines outside of urology and has cross-pollinated ideas and techniques with them. One of Dr. Stoller's fruitful interdisciplinary collaborations has been with Dr. Sunita Ho in the School of Dentistry. Working with her, he has leveraged correlative microscopy to help visualize stone formation. He has also developed insights from his work in the veterinary world–he has operated on many animals at the San Francisco Zoo, and worked with vets at UC Davis School of Veterinarian Medicine. He has also worked with collaborators at the Lawrence Berkeley Laboratory and the Molecular Foundry. Dr. Stoller is grateful for the support of his department, the School of Medicine and his loving family.
2020 RECIPIENT OF THE ENDOUROLOGY SOCIETY ‘‘INDUSTRY’’ AWARD
Born and raised in the city of Tuttlingen, Germany, the world center for medical technology with more than 500 medical device companies, Thekla Christina Koloczek was attracted early by the impact of the medical device industry on medicine and fascinated by what is possible with medical advancements to help humans.
After her studies of law and international business, Thekla started her career with KARL STORZ - Endoskope in 2004. Focused on training within the company in the beginning, she became a Marketing Urology Europe team member in 2011 and moved for KARL STORZ to the US subsidiary in El Segundo, CA in 2012 to expand her knowledge and market experience on a global base. She returned to headquarters in 2014.
With over 16 years of experience in the medical device industry Thekla is absolutely dedicated to the needs of nurses, technicians and urologists to help to solve challenges. She still loves to emphasize the importance of training and education within global partnerships and how we can learn from each other.
Thekla is incredibly thankful to be part of the global KARL STORZ Team, Pioneers in Endoscopy, and is proud to be in the important field of urology with all the outstanding innovations, working among the great group of urologists with long lasting cooperation's with the Endourological Society.
2021 RECIPIENT OF THE ‘‘ARTHUR’’ AWARD
Northwell Health's System Director for Prostate Cancer
Vice Chair at the Smith Institute for Urology at Lenox Hill
Dr. Art Rastinehad, D.O. initially joined the faculty at Northwell Health in 2011. Most recently, he was named Northwell Health's System Director for Prostate Cancer at the Cancer Institute and the Vice Chair at the Smith Institute for Urology at Lenox Hill Hospital (January 2020). He has expertise in a wide array of interventional radiological and surgical techniques, including image guided procedures, prostate artery embolization, laparoscopic and robotic surgery. These hybrid skills were developed under the patience and kindness of his mentors Gopal Badlani (uro), Peter Choyke (rad), Louis Kavoussi (uro), Marston Linehan (uro), Igor Lobko (rad), Peter Pinto (uro), David N. Siegel (rad), Arthur Smith (uro), and Bradford Wood (rad).
Dr. Rastinehad has dedicated his career to research and education. As a medical student he was awarded a full-scholarship as a teaching fellow in anatomy for his last three years of medical school. During this time Dr. Rastinehad joined the research group at the North Shore/Long Island Jewish (NSLIJ) Department of Urology and the Division of Interventional Radiology. His early research on Selective Arterial Prostatic Embolization (SAPE) for patients with refractory hematuria secondary to radiation prostatitis laid the foundation for his multidisciplinary approach, subsequently completing a urology residency and interventional radiology fellowship at North Shore LIJ in 2009. Soon after, Dr. Rastinehad trained at the National Cancer Institute (2009–2011) as an Interventional Urologic Oncologist and is the first urologist to be dual fellowship trained in Urologic Oncology and Interventional Radiology.
Dr. Rastinehad has also authored and implemented several clinical trials of new techniques in the diagnosis and treatment of localized prostate cancer. In 2011 at Northwell Heath, he was the principal investigator for a Phase III clinical trial using MRI/Ultrasound fusion technology to improve prostate biopsy techniques and validated the original work from the NIH's UOB/MIP/CIO programs. This was the first trial of this technology in the United States outside the National Institutes of Health. Dr. Rastinehad is considered one of the pioneers of this field, bringing prostate MRI and MR/US fusion guided prostate biopsy from the bench to clinical practice.
This new clinical approach is the groundwork for the evaluation of a new technique, Focal Therapy, which treats only the diseased portion of the prostate. While at the NIH, Dr. Rastinehad designed and authored the first trial assessing the utility of MR guided focal ablation of prostate tumors using MR US fusion biopsy data with Dr. Pinto as the PI (2010). As of May 2016, Dr Rastinehad was the first in the world to perform a gold nanoparticle directed ablation using a transperineal MR/US Fusion guided focal therapy system. This was the first-time nanoparticles were utilized to focally treat any cancer and this first series was recently published in Proceedings of the National Academy of Science (PNAS).
Dr Rastinehad is also one of the founding executive board members of the Focal Therapy Society (along with Drs. Polascik, De La Rosette, and Sanchez-Salas), which was started in October 2019 in collaboration with the Endourological Society. The society continues to grow and establish solid scientific principles to critically evaluate, disseminate, and perform focal therapy. In addition to his leadership role within the Focal Therapy Society, Dr. Rastinehad has been the course director and/or faculty for more than 30 courses nationally and internationally at the AUA, Endourological Society, Focal Therapy Society, and Société Internationale d'Urologie. Along with Dr. Pinto, he was the course director on the first use of MR/US fusion guided prostate biopsies in 2014. Continuing his goal to help bring these new treatments and approaches to the urologic community, he is currently developing the first Interventional Urology mobile platform combining image fusion, cone-beam CT/fluoroscopy, optical/EM tracking along with ESWL, ultrasound and the newest advances in radiation safety. These efforts will provide a platform for urologists to leverage these technologies and perform interventional treatments in their own operating rooms.
Dr. Rastinehad's research has been published in leading national and international medical journals.
He has published over 200 articles, videos, and multiple textbook chapters and was the senior editor of the first comprehensive textbook on the subject, ‘Interventional Urology’, in 2016. Dr. Rastinehad continues to dedicate his time to caring for patients by researching and developing new diagnostic and therapeutic interventions for urologic diseases, as well as training the next generation of urologists. He has formalized the training required for learning the skills of interventional urology (IU) with the establishment of the first and only IU program in the world.
2021 RECIPIENT OF THE RALPH CLAYMAN ‘‘MENTOR’’ AWARD
Dr. Ali Rıza Kural graduated from Istanbul University School of Medicine in 1974. He specialized in Urology at Cerrahpasa School of Medicine, Istanbul University. His main interests were endourology and urooncology. Dr. Kural worked in Edinburgh Western General Hospital between March and October 1985 as an honorary registrar. Then, he initiated one of the first endoscopic urinary stone treatment programs including ureteroscopic and percutaneous nephrolithotomy in 1986, and the first laparoscopic urological oncology program in 2002, in Turkey. He was the first to build a robotic urology program in the region in 2005, where more than 2750 robotic procedures were successfully completed.
Dr. Kural served as a Board member of European Robotic Urological Society (ERUS) between 2010 and 2016. He was a member of the Executive Committee of Endourological Society between 2017 and 2019. He served as President of the Endourological Society between 2017 and 2018. Dr. Kural was also an active member of the Board of Directors of Endourological Society. He successfully arranged many local and international scientific meetings and training courses, including the 30th World Congress of Endourology and SWL, which was held in Istanbul, Turkey in 2012 with 2,672 participants. Dr. Kural was Honorary Chair of Urology during the 22nd Society of Laparoendoscopic Surgeons (SLS) meeting in Reston, Virginia in 2013. He was recognized as a fellow of The Royal College of Physicians and Surgeons of Glasgow (RCPSG) in 2018. He is the first surgeon from Turkey to have received this award. He received special jury award of the Doktor Club organization, Istanbul, Turkey in 2019. Dr Kural is currently the chairman of the Minimally Invasive and Robotic Urology section in Acibadem University, Maslak Hospital, Istanbul, Turkey.
2021 RECIPIENT OF THE KARL STORZ ‘‘LIFETIME ACHIEVEMENT’’ AWARD
Dr. Tadashi Matsuda graduated from the Kyoto University School of Medicine in 1978, and was Professor and Chairman of the Department of Urology and Andrology, Kansai Medical University, Japan from 1995 to 2021. He is currently the Director of Kansai Medical University Hospital.
Dr. Matsuda has contributed to the field of endourology and urologic laparoscopy for 30 years. He performed a laparoscopic varicocelectomy in February 1990 and was among the first doctors to introduce laparoscopic surgery into daily urological practice. While Chair of the Committee of the Japanese Society of Endourology, he established a skill qualification system for urological laparoscopy which was the world's first nationwide skill evaluation system using video review. Dr. Matsuda and his team demonstrated the good predictive validity of the qualification and reliability of the video assessments. The skill qualification system is now planned to be introduced into Indonesia.
Dr. Matsuda's main research interest is the scientific evaluation of laparoscopic and robotic-assisted surgical skills. Using objective methods such as measurement of force applied on the instruments or a motion capture system, his team evaluated laparoscopic surgical dissection skill and surgeon's performance during robot-assisted surgery to establish the ideal technique. Other research topics have included the development of better management for urolithiasis and ureteral stents. He has published more than 270 manuscripts.
Dr. Matsuda served as the President of the Japanese Society of Endourology (2010–2012), and as President of the Endourological Society (2015–2016). He was the Congress President of the 29th World Congress of Endourology and SWL held in 2011 in Kyoto, Japan. He was also the Secretary General of the East Asian Society of Endourology (2016–2020). He was Chair of the Endoscopic Surgical Skill Qualification System Committee of the Japan Society of Endoscopic Surgery (JSES) (2010–2016). He served as President of the 28th Annual Congress of JSES in 2015. He is an International Member of the American Urological Association and the American Association of Genitourinary Surgeons.
2021 RECIPIENT OF THE ENDOUROLOGY SOCIETY ‘‘INDUSTRY’’ AWARD
With almost two decades of experience, Katy Lyall has earned a reputation as a passionate leader and innovator in the medical device field. Katy earned her bachelor's degree in Biomedical Engineering from the Georgia Institute of Technology with a focus in Neuroengineering. She has held leadership positions in clinical engineering, sales, and most recently led clinical marketing initiatives at Intuitive and is a passionate advocate and supporter of robotic surgery. Katy has worked closely with surgeon leaders, societies and engineers to advance minimally invasive procedures and innovation that maximize patient value throughout her career.
Katy has served on the board of directors with Baby Health Service, a not-for-profit children's medical clinic in Kentucky and completed the Executive Leadership Program at Stanford University in 2020. Katy is author of multiple publications and committed advocate for increased healthcare and education access for underserved communities. She is a devoted mother and wife and thrilled to now turn her focus to family, spending time traveling, and camping with her two children and husband, as well as devoting time to non-profit work to build educational and leadership opportunities to increase diversity and mentor the next generation of biomedical engineers.